MENINGIOMAS
Clinical trials for MENINGIOMAS explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMAS trials appear
Sign up with your email to follow new studies for MENINGIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on Hard-to-Treat brain tumors
Disease control OngoingThis phase 2 trial tests two immunotherapy drugs, nivolumab and ipilimumab, in 40 adults with progressive or recurrent meningioma. One group receives nivolumab alone; the other gets both drugs after radiation therapy. The goal is to see if these treatments can stop tumor growth f…
Matched conditions: MENINGIOMAS
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Brain zap aftermath: can we map and avoid memory loss?
Knowledge-focused OngoingThis study tracks 80 patients with brain tumors (metastases or meningiomas) who receive stereotactic radiosurgery. Researchers use memory tests and quality-of-life questionnaires before treatment and every 3 months for a year to see if and how brain function changes. By comparing…
Matched conditions: MENINGIOMAS
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC